Literature DB >> 15184489

Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection.

Catherine Gaudy1, Alain Moreau, Sylvie Brunet, Jean-Michel Descamps, Pascale Deleplanque, Denys Brand, Francis Barin.   

Abstract

We report a case of human immunodeficiency virus (HIV) type 1 infection not detected by a highly sensitive combined antigen-antibody assay. The virus was a subtype B strain harboring a unique sequence within the immunodominant epitope of the transmembrane glycoprotein. Immunochemical analysis indicated that this sequence was probably responsible for the failure to detect HIV antibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184489      PMCID: PMC427870          DOI: 10.1128/JCM.42.6.2847-2849.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.

Authors:  J Dorn; S Masciotra; C Yang; R Downing; B Biryahwaho; T D Mastro; J Nkengasong; D Pieniazek; M A Rayfield; D J Hu; R B Lal
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.

Authors:  F Barin; Y Lahbabi; L Buzelay; B Lejeune; A Baillou-Beaufils; F Denis; C Mathiot; S M'Boup; V Vithayasai; U Dietrich; A Goudeau
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-01       Impact factor: 2.205

3.  Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity.

Authors:  Bernard Weber; Lutz Gürtler; Rigmor Thorstensson; Ulrike Michl; Annelies Mühlbacher; Philippe Bürgisser; Roberto Villaescusa; Adolfo Eiras; Christian Gabriel; Herbert Stekel; Srivilai Tanprasert; Sinenaart Oota; Maria-Jose Silvestre; Cristina Marques; Maria Ladeira; Holger Rabenau; Annemarie Berger; Urban Schmitt; Walter Melchior
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection.

Authors:  T D Ly; L Martin; D Daghfal; A Sandridge; D West; R Bristow; L Chalouas; X Qiu; S C Lou; J C Hunt; G Schochetman; S G Devare
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers.

Authors:  C Yang; D Pieniazek; S M Owen; C Fridlund; J Nkengasong; T D Mastro; M A Rayfield; R Downing; B Biryawaho; A Tanuri; L Zekeng; G van der Groen; F Gao; R B Lal
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.

Authors:  R D Saville; N T Constantine; F R Cleghorn; N Jack; C Bartholomew; J Edwards; P Gomez; W A Blattner
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions.

Authors:  C Apetrei; I Loussert-Ajaka; D Descamps; F Damond; S Saragosti; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

8.  Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays.

Authors:  B Weber; E H Fall; A Berger; H W Doerr
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  8 in total
  7 in total

1.  Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Authors:  Shixing Tang; Jiangqin Zhao; Aifeng Wang; Ragupathy Viswanath; Harri Harma; Richard F Little; Robert Yarchoan; Susan L Stramer; Phillipe N Nyambi; Sherwin Lee; Owen Wood; Eric Y Wong; Xue Wang; Indira K Hewlett
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

2.  Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.

Authors:  Said Zouhair; Sylvie Roussin-Bretagne; Alain Moreau; Sylvie Brunet; Syria Laperche; Michèle Maniez; Francis Barin; Martine Harzic
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody.

Authors:  Maud Salmona; Severine Delarue; Constance Delaugerre; François Simon; Sarah Maylin
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

4.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

5.  Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection.

Authors:  Cécile Henquell; Christine Jacomet; Odile Antoniotti; Abdelhak Chaib; Christel Regagnon; Sylvie Brunet; Hélène Peigue-Lafeuille; Francis Barin
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

6.  Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States.

Authors:  Michael T Pyne; John Hackett; Vera Holzmayer; David R Hillyard
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

7.  Serological diagnosis and prevalence of HIV-1 infection in Russian metropolitan areas.

Authors:  D E Kireev; V P Chulanov; G A Shipulin; A V Semenov; E V Tivanova; N M Kolyasnikova; E B Zueva; V V Pokrovskiy; C Galli
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.